Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 343841 - 343860 out of 488720 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Norway | (L01DB03) epirubicin | Epirubicin Accord 2 mg/ml | 25 ml, Hetteglass, Injeksjons-/infusjonsvæske, oppløsning, 2 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | AccordHealthcareB.V. |
| Norway | (L01DC03) mitomycin | Mitomycin medac 1 mg/ml | 20 mg, Hetteglass, Pulver til intravesikaloppløsning/injeksjons-/infusjonsvæske, oppløsning, 1 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | Medac-GesellschaftfürklinischeSpezialpräparateGmbh-Wedel |
| Norway | (L01DC03) mitomycin | Mitomycin medac 1 mg/ml | 40 mg, Hetteglass, Pulver til intravesikaloppløsning/injeksjons-/infusjonsvæske, oppløsning, 1 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
n/a | Medac-GesellschaftfürklinischeSpezialpräparateGmbh-Wedel |
| Norway | (L01EJ01) ruxolitinib (adm: O) | Jakavi 15 mg | 56 stk, Blisterpakning, Tablett, 15 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | OrifarmAS |
| Norway | (L01EJ01) ruxolitinib (adm: O) | Jakavi 20 mg | 56 stk, Blisterpakning, Tablett, 20 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Myeloproliferative Disorders;Polycythemia Vera;Graft vs Host Disease | OrifarmAS |
| Norway | (L01EX04) vandetanib (adm: O) | Caprelsa 100 mg | 30 stk, Blisterpakning, Tablett, filmdrasjert, 100 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | SanofiB.V. |
| Norway | (L01EX04) vandetanib (adm: O) | Caprelsa 300 mg | 30 stk, Blisterpakning, Tablett, filmdrasjert, 300 mg , Blisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | SanofiB.V. |
| Norway | (L01EX07) cabozantinib (adm: O) | Cometriq <multi> |
28 stk, Blisterpakning,, |
Retail price with vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | IpsenPharma |
| Norway | (L01EX07) cabozantinib (adm: O) | Cometriq <multi> |
28 stk, Blisterpakning,, |
Retail price with vat |
$0-0 |
$0-0 |
Thyroid Neoplasms | IpsenPharma |
| Norway | (L01EX09) nintedanib (adm: O) | Ofev 100 mg | 60 x 1 stk, Endoseblisterpakning, Kapsel, myk, 100 mg , Endoseblisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Idiopathic Pulmonary Fibrosis | BoehringerIngelheimInternationalGmbH |
| Norway | (L01EX09) nintedanib (adm: O) | Ofev 150 mg | 60 x 1 stk, Endoseblisterpakning, Kapsel, myk, 150 mg , Endoseblisterpakning | Retail price with vat |
$0-0 |
$0-0 |
Idiopathic Pulmonary Fibrosis | BoehringerIngelheimInternationalGmbH |
| Norway | (L01FA01) rituximab | MabThera 1 400 mg | 11.7 ml, Hetteglass, Injeksjonsvæske, oppløsning, 1 400 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Leukemia, Lymphocytic, Chronic, B-Cell | RocheRegistrationGmbH |
| Norway | (L01FA01) rituximab | MabThera 1 600 mg | 13.4 ml, Hetteglass, Injeksjonsvæske, oppløsning, 1 600 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Lymphoma, Non-Hodgkin;Arthritis, Rheumatoid;Leukemia, Lymphocytic, Chronic, B-Cell | RocheRegistrationGmbH |
| Norway | (L01FD01) trastuzumab | Herceptin 150 mg | 150 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 150 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | RocheRegistrationGmbH |
| Norway | (L01FD01) trastuzumab | Ogivri 150 mg | 150 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 150 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BiosimilarCollaborationsIrelandLimited |
| Norway | (L01FD01) trastuzumab | Zercepac 150 mg | 150 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 150 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | AccordHealthcareS.L.U. |
| Norway | (L01FD01) trastuzumab | Ogivri 420 mg | 420 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 420 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | BiosimilarCollaborationsIrelandLimited |
| Norway | (L01FD01) trastuzumab | Zercepac 420 mg | 420 mg, Hetteglass, Pulver til konsentrat til infusjonsvæske, oppløsning, 420 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | AccordHealthcareS.L.U. |
| Norway | (L01FF04) avelumab | Bavencio 20 mg/ml | 10 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 20 mg/ml , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Neuroendocrine Tumors | OrifarmAS |
| Norway | (L01FF05) atezolizumab | Tecentriq 1 200 mg | 20 ml, Hetteglass, Konsentrat til infusjonsvæske, oppløsning, 1 200 mg , Hetteglass | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;Breast Neoplasms;Small Cell Lung Carcinoma | OrifarmAS |
Pages
